Evaluation of different wound dressings in the treatment of children with spoke injuries
Recruiting
- Conditions
- spokewound1002211410040790injury after a foot between bicycle spokes
- Registration Number
- NL-OMON44741
- Lead Sponsor
- oordwest Ziekenhuisgroep
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 108
Inclusion Criteria
Children of 4 years of age and older.
Presentation within 72 hours after trauma
Wound on foot and/or ankle after inury where foot has been stuck in between spokes of riding bicycle.
Exclusion Criteria
Children younger than 4 years,
Adults
unable to score pain on painscale
Allergic to a component of one of the bandages
Indication for surgery of underlying muscle, tendon or bone
No skin defect
Follow-up in another hospital
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Pain, as measured with Faces pain scale revised and a FLACC score</p><br>
- Secondary Outcome Measures
Name Time Method <p>length of treatment in days<br /><br>development of wound infection as scored with South-Hampton wound assessment<br /><br>scale</p><br>
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie wound healing in pediatric spokewound injuries treated with advanced dressings?
How do experimental wound dressings in the SPOKE-trial compare to standard-of-care hydrocolloid or silver-impregnated dressings in pediatric trauma management?
Which biomarkers (e.g., cytokine profiles, infection indicators) predict optimal response to novel wound dressings in NL-OMON44741?
What adverse events are associated with biodegradable vs. non-adherent wound dressings in children with bicycle-spoke foot injuries?
Are there combination therapies involving antimicrobial agents or growth factors that enhance outcomes for spokewound treatment in pediatric populations?